Acer Therapeutics Inc (NASDAQ:ACER)

2.51
BATS BZX Real-Time Price
As of 1:31pm ET
 -0.06 / -2.33%
Today’s Change
1.08
Today|||52-Week Range
7.25
-37.41%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +298.41% increase from the last price of 2.51.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Acer Therapeutics Inc. This rating has held steady since August, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.46
Sales
$0.00
Reporting Date
Nov 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.86%
 
 
 
 
 
 
Growthannually 35.57%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.